203 related articles for article (PubMed ID: 11237489)
1. Expression patterns of beta-catenin in in situ and invasive breast cancer.
Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M
Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
4. Β-catenin expression in in situ and infiltrative ductal carcinomas of the breast.
Karabacak T; Eğılmez R; Arpaci RB; Pfeiffer ES
Turk Patoloji Derg; 2011; 27(3):185-8. PubMed ID: 21935866
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin and catenins in invasive mammary carcinomas.
Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
7. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments].
Bukholm IK; Nesland JM; Børresen-Dale AL
J Pathol; 2000 Jan; 190(1):15-9. PubMed ID: 10640987
[TBL] [Abstract][Full Text] [Related]
8. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
9. [Expression of cell adhesion molecules E-cadherin and beta-catenin in infiltrating breast carcinoma].
Chipysheva TA; Gel'shteĭn VI; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2003; 65(3):3-7. PubMed ID: 12879601
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model.
Sormunen RT; Leong AS; Vääräniemi JP; Fernando SS; Eskelinen SM
J Pathol; 1999 Mar; 187(4):416-23. PubMed ID: 10398100
[TBL] [Abstract][Full Text] [Related]
11. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
Zou W; Hu CH; Zhou JP
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
[TBL] [Abstract][Full Text] [Related]
13. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL
J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365
[TBL] [Abstract][Full Text] [Related]
14. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
15. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
Yang JF; Chen SL; Liu ZH; Zhang Y
Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915
[TBL] [Abstract][Full Text] [Related]
16. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
18. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development.
Honecker F; Kersemaekers AM; Molier M; Van Weeren PC; Stoop H; De Krijger RR; Wolffenbuttel KP; Oosterhuis W; Bokemeyer C; Looijenga LH
J Pathol; 2004 Oct; 204(2):167-74. PubMed ID: 15378486
[TBL] [Abstract][Full Text] [Related]
19. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
20. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
